These results suggest that the three risk loci are largely specific to ER-negative but not triple-negative breast cancer, in contrast to loci in the MDM4, LGR6, 19p13.1 and TERT regions3, 17. This evidence concerns the gene TERT and triple-negative breast carcinoma.